Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyosarcoma × Surgical Procedures, Operative × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 7 Brain Neoplasms 6 Rectal Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Glioblastoma 3 Uterine Cervical Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Inflammatory Breast Neoplasms 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma 2 Vaginal Neoplasms 1 Testicular Neoplasms 1 Teratoma 1

Interventions

Doxorubicin 7 Ifosfamide 5 Radiotherapy 3 Trabectedin 2 Filgrastim 2 Dacarbazine 2 pegfilgrastim 1 olaratumab 1 indolepropanol phosphate 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Radiotherapy, Conformal 1 PM 01183 1 Observation 1 Neoadjuvant Therapy 1 Combined Modality Therapy 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04031677 2026-03-18

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡